AMA
Szymanska E, Dadalski M, Oracz G, Kierkus J. Safety profile of biologic therapy in Polish paediatric patients with Crohn’s disease. Gastroenterology Review/Przegląd Gastroenterologiczny. 2015;10(3):164-168. doi:10.5114/pg.2015.52298.
APA
Szymanska, E., Dadalski, M., Oracz, G., & Kierkus, J. (2015). Safety profile of biologic therapy in Polish paediatric patients with Crohn’s disease. Gastroenterology Review/Przegląd Gastroenterologiczny, 10(3), 164-168. https://doi.org/10.5114/pg.2015.52298
Chicago
Szymanska, Edyta, Maciej Dadalski, Grzegorz Oracz, and Jarosław Kierkus. 2015. "Safety profile of biologic therapy in Polish paediatric patients with Crohn’s disease". Gastroenterology Review/Przegląd Gastroenterologiczny 10 (3): 164-168. doi:10.5114/pg.2015.52298.
Harvard
Szymanska, E., Dadalski, M., Oracz, G., and Kierkus, J. (2015). Safety profile of biologic therapy in Polish paediatric patients with Crohn’s disease. Gastroenterology Review/Przegląd Gastroenterologiczny, 10(3), pp.164-168. https://doi.org/10.5114/pg.2015.52298
MLA
Szymanska, Edyta et al. "Safety profile of biologic therapy in Polish paediatric patients with Crohn’s disease." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 10, no. 3, 2015, pp. 164-168. doi:10.5114/pg.2015.52298.
Vancouver
Szymanska E, Dadalski M, Oracz G, Kierkus J. Safety profile of biologic therapy in Polish paediatric patients with Crohn’s disease. Gastroenterology Review/Przegląd Gastroenterologiczny. 2015;10(3):164-168. doi:10.5114/pg.2015.52298.
